20 research outputs found
Virtual target screening to rapidly identify potential protein targets of natural products in drug discovery
Inherent biological viability and diversity of natural products make them a potentially rich source for new therapeutics. However, identification of bioactive compounds with desired therapeutic effects and identification of their protein targets is a laborious, expensive process. Extracts from organism samples may show desired activity in phenotypic assays but specific bioactive compounds must be isolated through further separation methods and protein targets must be identified by more specific phenotypic and in vitro experimental assays. Still, questions remain as to whether all relevant protein targets for a compound have been identified. The desire is to understand breadth of purposing for the compound to maximize its use and intellectual property, and to avoid further development of compounds with insurmountable adverse effects. Previously we developed a Virtual Target Screening system that computationally screens one or more compounds against a collection of virtual protein structures. By scoring each compound-protein interaction, we can compare against averaged scores of synthetic drug-like compounds to determine if a particular protein would be a potential target of a compound of interest. Here we provide examples of natural products screened through our system as we assess advantages and shortcomings of our current system in regards to natural product drug discovery
The Changing Landscape for Stroke\ua0Prevention in AF: Findings From the GLORIA-AF Registry Phase 2
Background GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non\u2013vitamin K antagonist oral anticoagulant (NOAC), became available. Objectives This study sought to describe phase 2 baseline data and compare these with the pre-NOAC era collected during phase 1. Methods During phase 2, 15,641 consenting patients were enrolled (November 2011 to December 2014); 15,092 were eligible. This pre-specified cross-sectional analysis describes eligible patients\u2019 baseline characteristics. Atrial fibrillation disease characteristics, medical outcomes, and concomitant diseases and medications were collected. Data were analyzed using descriptive statistics. Results Of the total patients, 45.5% were female; median age was 71 (interquartile range: 64, 78) years. Patients were from Europe (47.1%), North America (22.5%), Asia (20.3%), Latin America (6.0%), and the Middle East/Africa (4.0%). Most had high stroke risk (CHA2DS2-VASc [Congestive heart failure, Hypertension, Age 6575 years, Diabetes mellitus, previous Stroke, Vascular disease, Age 65 to 74 years, Sex category] score 652; 86.1%); 13.9% had moderate risk (CHA2DS2-VASc = 1). Overall, 79.9% received oral anticoagulants, of whom 47.6% received NOAC and 32.3% vitamin K antagonists (VKA); 12.1% received antiplatelet agents; 7.8% received no antithrombotic treatment. For comparison, the proportion of phase 1 patients (of N = 1,063 all eligible) prescribed VKA was 32.8%, acetylsalicylic acid 41.7%, and no therapy 20.2%. In Europe in phase 2, treatment with NOAC was more common than VKA (52.3% and 37.8%, respectively); 6.0% of patients received antiplatelet treatment; and 3.8% received no antithrombotic treatment. In North America, 52.1%, 26.2%, and 14.0% of patients received NOAC, VKA, and antiplatelet drugs, respectively; 7.5% received no antithrombotic treatment. NOAC use was less common in Asia (27.7%), where 27.5% of patients received VKA, 25.0% antiplatelet drugs, and 19.8% no antithrombotic treatment. Conclusions The baseline data from GLORIA-AF phase 2 demonstrate that in newly diagnosed nonvalvular atrial fibrillation patients, NOAC have been highly adopted into practice, becoming more frequently prescribed than VKA in Europe and North America. Worldwide, however, a large proportion of patients remain undertreated, particularly in Asia and North America. (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation [GLORIA-AF]; NCT01468701
β-Strand Mimics based on Tetrahydropyridazinedione (tpd) Peptide Stitching
Short peptides featuring a tetrahydropyridazinedione (tpd) backbone tether exhibit reduced conformational flexibility external to the heterocyclic constraint. Analysis by NMR, molecular modeling and X-ray crystallography suggests both covalent and non-covalent stabilization of extended peptide conformations. An efficient solid-phase protocol was developed for the synthesis of a new class of β-strand mimics based on oligomeric tpd subunits
Ligand-mediated Protein Degradation reveals Functional Conservation among Sequence Variants of the CUL4-type E3 Ligase Substrate Receptor Cereblon
Upon binding to thalidomide and other immunomodulatory drugs, the E3 ligase substrate receptor cereblon (CRBN) promotes proteosomal destruction by engaging the DDB1–CUL4A–Roc1–RBX1 E3 ubiquitin ligase in human cells but not in mouse cells, suggesting that sequence variations in CRBN may cause its inactivation. Therapeutically, CRBN engagers have the potential for broad applications in cancer and immune therapy by specifically reducing protein expression through targeted ubiquitin-mediated degradation. To examine the effects of defined sequence changes on CRBN\u27s activity, we performed a comprehensive study using complementary theoretical, biophysical, and biological assays aimed at understanding CRBN\u27s nonprimate sequence variations. With a series of recombinant thalidomide-binding domain (TBD) proteins, we show that CRBN sequence variants retain their drug-binding properties to both classical immunomodulatory drugs and dBET1, a chemical compound and targeting ligand designed to degrade bromodomain-containing 4 (BRD4) via a CRBN-dependent mechanism. We further show that dBET1 stimulates CRBN\u27s E3 ubiquitin–conjugating function and degrades BRD4 in both mouse and human cells. This insight paves the way for studies of CRBN-dependent proteasome-targeting molecules in nonprimate models and provides a new understanding of CRBN\u27s substrate-recruiting function
A review of innovation strategies and processes to improve access to AT: looking ahead to open innovation ecosystems
A ‘minority' on the move: Boundary work among Filipina Muslim migrant domestic workers in the Middle East
This article analyses the migration of a religious ‘minority’ that is largely invisible within migration studies, namely Muslim Filipina domestic workers. More specifically, this research shows that the category of ‘minority’ is not fixed and is always negotiated through transnational spaces and boundary work. In doing so, the article highlights how religious belonging, the status of minority and migration intersect and are negotiated during the period prior to these women leaving their country, during their time in the country of destination, and when they return to the Philippines. How boundary work affects the religious belonging of this Muslim ‘minority’ is underlined by presenting the Middle East as an opportunity to perform norms of ‘Muslimness’. The performance of these norms as an opportunity for these women to challenge the status of being a ‘minority’ in the Philippines is also examined. Finally, this article shows how these Muslim ‘minorities’ gain access to a certain symbolic capital by becoming hajji and balikbayan (returnees) when they return home
A ‘Minority’ on the Move: Boundary Work among Filipina Muslim Migrant Domestic Workers in the Middle East
Organization, decoration
While organizational decoration has been of interest to those who study organizational artefacts, we suggest four ways in which decoration is worthy of fuller attention in organizational studies. First, decoration, ornament and embellishment are not only what we see, but also what we do as managers, consultants, writers and designers of both physical and project spaces. Second, and drawing on the art/craft debate, we note that decoration occupies contested and even liminal aesthetic position and that ‘decorative art’ lies betwixt and between fine art and craft. Neither fully accepted nor fully marginalized, decoration is ‘only applied’ and embodies shifting tensions between form and function. Third, we review the particular negotiations of these tensions at the Bauhaus, a controversial and highly influential aesthetic organization in early 20th century Germany. Fourth, we suggest that decoration, like disorganization, provides a source of complication for organizational studies that are neither pure nor parsimonious.<br /